When a company hits Inc. 5000 No. 18 velocity, the visible growth story is only half the picture. The other half is what gets built underneath to keep the visible part from breaking.
RazorMetrics, named No. 18 on the 2025 Inc. 5000 list of America's fastest-growing private companies.
RazorMetrics builds pharmacy cost containment technology for self-funded employers, health plans, and pharmacy benefit managers. Their proprietary platform identifies medication switches, deprescription opportunities, and deduplications, then routes those savings into prescriber workflows without breaking the clinical flow.
The company was co-founded by Dr. Siva Mohan, a cardiologist who saw the affordability gap from inside the exam room, and Tom Dorsett, a serial entrepreneur with a long record in healthcare technology. Both were named Ernst & Young Entrepreneur Of The Year 2025 Gulf South Award winners earlier this year.
RazorMetrics is not in the business of marginal savings. The mission is closer to a public health problem. In April 2025, the company released its 2025 State of Drug Access report, finding that nearly half of Americans have been prescribed medications they could not afford. That is the gap the platform is built to close, one prescription at a time.
As a cardiologist, I've seen firsthand how opaque and unpredictable medication pricing can cause clinical disruption and confusion for patients and their physicians alike.
That framing, drug pricing as a clinical problem rather than a procurement problem, shapes how the company builds. The technology has to live inside the prescriber's existing workflow, adapt to each client's formulary, and surface savings without adding friction to the moment a doctor is writing a script.
In August 2025, Inc. named RazorMetrics No. 18 on its 5000 list of America's fastest-growing private companies. That same list has, over the years, included Microsoft, Meta, Oracle, and Patagonia early in their trajectories. The top 500 companies on the 2025 list posted a median three-year revenue growth of more than 1,500 percent.
Debuting at No. 18 is beyond anything I imagined. It's a testament to the extraordinary team we've built and the real-world impact we're making by helping people afford the medications they need.
Growth of this kind never arrives clean. More deals, more prescribers, more plan sponsors, more PBMs, and a team that scales geographically as the business does. Every new conversation needs alignment across schedules, time zones, and tooling. Every delay in scheduling is a delay in revenue.
For a healthcare company specifically, the coordination problem has a unique shape. Deals do not happen in isolation. They unfold across internal teams (sales, clinical, engineering, executive) and external partners (prescribers, plan sponsors, PBMs, health plan administrators). The coordination surface multiplies with every new customer, not linearly with headcount.
Marketing and operations leaders at fast-growing healthcare companies consistently name internal and external scheduling coordination as a top operational drag. The reason is not tooling availability. It is tooling fit.
At Inc. 5000 velocity, scheduling is not a feature. It is infrastructure. The requirements stack up fast and they are not negotiable:
These are not nice-to-haves. They are the floor for any scheduling layer being evaluated by a fast-growth healthcare team. The companies that hit Inc. 5000 velocity tend to discover this the hard way, somewhere between hiring number twenty and customer number fifty.
This is the space TEAMCAL AI was built for. Multi-stakeholder TeamLinks, Slack-native AdiBot, Zara AI for external email coordination, full compliance posture. Built for the moment when scheduling becomes infrastructure, not a moment before.
The pattern visible in RazorMetrics' growth is visible across the Inc. 5000 healthcare cohort more broadly. Companies scaling at this velocity discover, often the hard way, that the coordination layer underneath the business has to scale with the business. Companies that nail it scale clean. Companies that do not bleed revenue and momentum to scheduling friction they never fully see.
The category itself is shifting. Scheduling tools built for individual productivity are giving way to scheduling infrastructure built for teams. The companies leading this shift are the ones building underneath the growth, not bolted alongside it.
Most coverage of Inc. 5000 winners focuses on what they sell. The more interesting story is often what they build underneath, the operating systems that let the front end of the business scale without breaking. Coordination is one of those systems. It looks small from a distance. Up close, it is the difference between momentum and friction.
The growth gets the headline.
The coordination layer keeps the growth alive.
Both have to scale together.
RazorMetrics is one of many companies discovering this in real time. The ones that solve it cleanly are the ones that keep growing.
Explore TEAMCAL AI